$0.5100
0.01442.91%
Dern. MÀJ: Oct 23, 8:29 AM
Jasper Therapeutics (JSPR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.52 | $-0.52 | $-0.81 | $-1.18 |
| Actual | $-0.10 | $-0.04 | $-0.32 | $-1.13 |
| Surprise | +80.8% | +92.3% | +60.5% | +4.24% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.46 | $-0.66 | $-0.03 | $-0.03 |
| Revenue | ||||
| Consensus | $4.3M | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.10 | $-0.52 | 80.8 % |
| Q1 | May 14, 2026 | $-0.04 | $-0.52 | 92.3 % |
| Q4 | Mar 30, 2026 | $-0.32 | $-0.81 | 60.5 % |
| Q3 | Nov 10, 2025 | $-1.13 | $-1.18 | 4.24 % |